Amphion Innovations plc is a principal investment firm specializing in both public and private early stage investments and spun out of universities and corporations. It does not invest in “speculative” technologies requiring long development timeframes or excessive capital investment. It invests in the medical, life sciences, and technology sectors with defensible core intellectual property, know-how and growth potential in very large markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs. The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceut...
125 Park Avenue
New York, NY 10017
Founded in 1984
Amphion Innovations plc Announces Additional Draw Down Facility on its Loan Facility
Jul 13 16
Amphion Innovations plc announced that the company has agreed terms for the draw-down of an additional tranche of $750,000 (an 'Additional Draw') under the loan facility as initially announced on June 5, 2014 (the 'Facility'). The company will receive the proceeds of the Additional Draw immediately. Under the terms of the Additional Draw, nil interest is charged with a repayment amount of $881,250 due on 6 October 2016. The proceeds of the Additional Draw are to be used to partially repay the existing amount due under the Facility and for working capital for Amphion and its Partner Companies. The Additional Draw may be converted into Ordinary Shares in Amphion in accordance with the additional terms of the Facility announced on 29 April 2016. The Additional Draw is to be secured by the Company pledging an additional amount of marketable securities, equivalent in value to $900,000, within 30 days of this announcement.
Amphion Innovations plc Reports Audited Consolidated and Company Earnings Results for the Year Ended December 31, 2015
Jun 23 16
Amphion Innovations Plc reported audited consolidated and company earnings results for the year ended December 31, 2015. For the year, on consolidated basis, revenue was USD 519,855 against USD 484,700 a year ago. Operating loss was USD 4,160,357 against USD 3,009,651 a year ago. Profit before tax was USD 5,943,699 against loss of USD 12,589,279 a year ago. Profit for the year was USD 5,941,799 against loss of USD 12,589,721 a year ago. Profit per share - diluted was USD 0.02 against loss of USD 0.09 per basic and diluted share a year ago. Net cash used in operating activities was USD 2,825,264 against USD 3,127,428 a year ago. Purchases of investments were USD 402,015 against USD 286,259 a year ago.
On company basis, profit was USD 5,219,730 against loss of USD 10,880,335 a year ago. Net cash used in operating activities was USD 2,896,162 against loss of USD 3,156,586 a year ago. Purchases of investments were USD 402,015 against USD 286,259 a year ago.
Amphion Innovations Plc Auditor Raises 'Going Concern' Doubt
Jun 23 16
Amphion Innovations Plc filed its Annual on Jun 23, 2016 for the period ending Dec 31, 2015. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.